Sign in
4

Changes in Ownership

CRISPR Therapeutics AG Filed Acc 0000899243-18-012101

Director sold 121,362 shares at an average $50.39 ($6,115,873)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Woiwode Thomas Director 2018-05-07 Sale −97,550 $50.31 $4,907,741 1,199,784 I
Woiwode Thomas Director 2018-05-07 Sale −2,862 $50.31 $143,987 35,202 I
Woiwode Thomas Director 2018-05-07 Sale −3,172 $50.31 $159,583 39,021 I
Woiwode Thomas Director 2018-05-07 Sale −7,424 $50.31 $373,501 91,312 I
Woiwode Thomas Director 2018-05-07 Sale −7,645 $51.26 $391,883 1,192,139 I
Woiwode Thomas Director 2018-05-07 Sale −225 $51.26 $11,534 34,977 I
Woiwode Thomas Director 2018-05-07 Sale −249 $51.26 $12,764 38,772 I
Woiwode Thomas Director 2018-05-07 Sale −582 $51.26 $29,833 90,730 I
Woiwode Thomas Director 2018-05-08 Sale −1,653 $51.45 $85,047 5,629 D
Open-market sales · 121,362 sh · avg $50.39 · $6,115,873
Loading xslF345X03/doc4.xml…